USA - NYSE:ABEV - US02319V1035 - ADR
ChartMill assigns a Buy % Consensus number of 54% to ABEV. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating | 
|---|---|---|---|
| 2025-08-20 | UBS | Maintains | Neutral -> Neutral | 
| 2025-08-01 | HSBC | Downgrade | Buy -> Hold | 
| 2025-06-04 | UBS | Maintains | Neutral -> Neutral | 
| 2025-05-12 | Barclays | Maintains | Equal-Weight -> Equal-Weight | 
| 2025-04-22 | UBS | Downgrade | Buy -> Neutral | 
| 2025-04-07 | Morgan Stanley | Downgrade | Equal-Weight -> Underweight | 
| 2025-01-22 | Citigroup | Downgrade | Buy -> Neutral | 
| 2025-01-21 | Barclays | Maintains | Equal-Weight -> Equal-Weight | 
| 2024-07-31 | UBS | Maintains | Buy -> Buy | 
| 2024-05-09 | Barclays | Maintains | Equal-Weight -> Equal-Weight | 
| 2024-03-04 | Barclays | Downgrade | Overweight -> Equal-Weight | 
| 2023-11-22 | Jefferies | Initiate | Hold | 
| 2023-05-24 | Bernstein | Initiate | Outperform | 
| 2022-07-13 | JP Morgan | Upgrade | Neutral -> Overweight | 
| 2021-11-03 | B of A Securities | Upgrade | Underperform -> Neutral | 
| 2021-10-06 | Barclays | Upgrade | Equal-Weight -> Overweight | 
21 analysts have analysed ABEV and the average price target is 2.52 USD. This implies a price increase of 9.53% is expected in the next year compared to the current price of 2.3.
The consensus rating for AMBEV SA-ADR (ABEV) is 54.2857 / 100 . This indicates that analysts generally have a neutral outlook on the stock.